Recombinant hybrid immunogloblin molecules an method of use

Details Recombinant hybrid immunogloblin molecules an method of use Recombinant hybrid immunogloblin molecules an method of use

C - Chemistry, Metallurgy

12

N

530/15.06, 195/1

C12N 15/62 (2006.01) A61K 38/49 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) C07K 16/36 (2006.01) C12N 9/72 (2006.01) C12N 15/13 (2006.01) C12N 15/58 (2006.01) G01N 33/577 (2006.01)

Patent

CA 1339546

This invention relates to a recombinant hybrid immunoglobulin molecule having an antigen binding site specific for fibrin linked to a second protein comprising the active portion of a plasminogen activator, single-chain urokinase. The invention is also directed to the cloning and production of these novel hybrid immunoglobulin molecules. This invention further relates to a method of using these recombinant hybrid immunoglobulin molecules in immunodiagnostic and immunotherapeutic processes.

608894

Affiliated with

Also associated with

Rating

Recombinant hybrid immunogloblin molecules an method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant hybrid immunogloblin molecules an method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant hybrid immunogloblin molecules an method of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1230348